| Esther Yeboah-awusi, CRNP | |
|
680 Blair Mill Rd, Ste. 400, Horsham, PA 19044-2223 | |
| (267) 965-7962 | |
| Not Available |
| Full Name | Esther Yeboah-awusi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 680 Blair Mill Rd, Horsham, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053589317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | SP008097 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Esther Yeboah-awusi, CRNP 680 Blair Mill Rd, Ste. 400, Horsham, PA 19044-2223 Ph: (267) 965-7962 | Esther Yeboah-awusi, CRNP 680 Blair Mill Rd, Ste. 400, Horsham, PA 19044-2223 Ph: (267) 965-7962 |
News Archive
Two Mount Sinai School of Medicine researchers are among a select group of scientists from around the world who have been recognized by the National Cancer Institute (NCI) for their quest to answer the most pressing questions about cancer. Stuart Aaronson, MD, Professor and Chair of Oncological Sciences and Ross Cagan, PhD, Professor of Oncological Sciences at Mount Sinai, have received the NCI's new "Provocative Questions" grant, which was established to explore the important yet less obvious questions about cancer that may have been neglected in this era of significant discovery.
Would you notice if all the objects around you simultaneously moved farther away? In a virtual-reality laboratory in Oxford, researchers have obtained the puzzling finding that humans can be "blind" to changes like this.
Peter Turkeltaub, MD, PhD, assistant professor of neurology and rehabilitation medicine, and director of the Cognitive Recovery Lab, has been chosen by an international society of neurologists to receive its annual award for excellence in behavioral neurology research.
A combination therapy of ivosenidib (IVO) plus venetoclax (VEN) with or without azacitidine (AZA) was found to be effective against a specific genetic subtype of acute myeloid leukemia (AML) in a Phase Ib/II trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 1 days ago
Cynthia J Barrow, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3 Village Rd, Suite 100, Horsham, PA 19044 Phone: 215-884-7114 Fax: 215-884-7147 | |
Mrs. Diane Louise Troutman, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 680 Blair Mill Rd, Horsham, PA 19044 Phone: 717-919-6300 | |
Alice Beatrice Wilson-horton, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 401 Horsham Rd, Horsham, PA 19044 Phone: 267-422-8240 | |
Amy Susan Blake, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 680 Blair Mill Rd, Horsham, PA 19044 Phone: 302-304-6341 | |
Hiral Patel, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 680 Blair Mill Rd, Horsham, PA 19044 Phone: 215-902-9020 | |
Vanessa Rae Fischer, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 680 Blair Mill Rd, Horsham, PA 19044 Phone: 412-956-5567 | |
Tamika Mickie, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 680 Blair Mill Rd, Horsham, PA 19044 Phone: 484-781-5933 |